Dalcetrapib

1-(2-Ethylbutyl)-N-{2-[(2-methylpropanoyl)sulphanyl]phenyl}cyclohexane-1-carboximidic acid

Formula: C23H35NO2S (389.2388)
Chinese Name: CETP抑制剂
BioDeep ID: BioDeep_00000177935 ( View LC/MS Profile)
SMILES: CCC(CC)CC1(CCCCC1)C(=O)NC1=CC=CC=C1SC(=O)C(C)C



Found 2 Sample Hits

m/z Adducts Species Organ Scanning Sample
390.2502 [M+H]+
PPM:10.5		 Homo sapiens esophagus DESI ()
LNTO22_1_4 - MTBLS385
Resolution: 17μm, 82x80

Description

354.226 [M+H-2H2O]+
PPM:2.9		 Homo sapiens esophagus DESI ()
TO31T - MTBLS385
Resolution: 75μm, 56x54

Description


D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D009676 - Noxae > D000963 - Antimetabolites Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Dalcetrapib (JTT-705) is an orally active cholesteryl ester transfer protein (CETP) inhibitor with IC50s of 204.6 nM and 6 μM against recombinant human (rh) CETP and human plasma CETP, respectively[1][2].